Vimarsana
Biggest News Aggregation in the World

Chris Bunka News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chris Bunka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chris Bunka Today - Breaking & Trending Today

Lexaria Bioscience Corp.: Lexaria Awards Contract For Third GLP-1 Human Pilot Study - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Awards Contract For Third GLP-1 Human Pilot Study

Published: May 23, 2024

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company"

Source: finanznachrichten.de
Related Topics:
George JurcicChris BunkaEli LillyExchange CommissionLexaria Bioscience CorpCompany Or LexariaDrug AdministrationLexaria BioscienceReview BoardIhr Portfolio
Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise ... - Vimarsana News

Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise ...

Published: April 30, 2024

Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise ...

Source: pr-inside.com
Related Topics:
United StatesChris BunkaLexaria Bioscience CorpNews NetworkCompany Or LexariaExchange CommissionDrug AdministrationLexaria BioscienceSecurities Act
Lexaria Bioscience : Corporate Highlight Sheet -November 02, 2023 at 01:09 pm EDT - Vimarsana News

Lexaria Bioscience : Corporate Highlight Sheet -November 02, 2023 at 01:09 pm EDT

Published: November 2, 2023

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...

Source: marketscreener.com
Related Topics:
British ColumbiaJohn DochertyChris BunkaLexaria CorpLexaria Nutraceutical CorpSecurities ExchangeLexaria NicotineAltria CorpHealth CanadaLexaria Bioscience CorpLexaria Hemp CorpLexaria Pharmaceutical CorpFatty Acid OilHelix Biopharma CorpLexaria Peer Reviewed Published ResearchDrug AdministrationStudy ProgramAltria GroupBioscience CorpActive Pharmaceutical IngredientsInvestigational New DrugMccurdy RoadHypoxic Pulmonary VasoconstrictionSwedish MatchClinical Study
Lexaria Bioscience : Corporate Highlight Sheet -October 24, 2023 at 05:49 pm EDT - Vimarsana News

Lexaria Bioscience : Corporate Highlight Sheet -October 24, 2023 at 05:49 pm EDT

Published: October 24, 2023

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...

Source: marketscreener.com
Related Topics:
British ColumbiaJohn DochertyChris BunkaAltria GroupLexaria Nutraceutical CorpFatty Acid OilHealth CanadaLexaria Peer Reviewed Published ResearchDrug AdministrationStudy ProgramHelix Biopharma CorpLexaria Hemp CorpLexaria Pharmaceutical CorpLexaria NicotineSecurities ExchangeLexaria CorpAltria CorpLexaria Bioscience CorpBioscience CorpActive Pharmaceutical IngredientsInvestigational New DrugMccurdy RoadHypoxic Pulmonary VasoconstrictionSwedish MatchClinical Study
Lexaria Bioscience : Corporate Highlight Sheet -Today at 06:47 pm - Vimarsana News

Lexaria Bioscience : Corporate Highlight Sheet -Today at 06:47 pm

Published: September 6, 2023

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...

Source: marketscreener.com
Related Topics:
British ColumbiaJohn DochertyChris BunkaLexaria NicotineAltria CorpLexaria CorpDrug AdministrationLexaria Peer Reviewed Published ResearchLexaria Hemp CorpHelix Biopharma CorpLexaria Bioscience CorpStudy ProgramSecurities ExchangeLexaria Pharmaceutical CorpFatty Acid OilAltria GroupBioscience CorpActive Pharmaceutical IngredientsInvestigational New DrugMccurdy RoadHypoxic Pulmonary VasoconstrictionSwedish MatchClinical StudyPeer Reviewed Published ResearchHelix Biopharma